When Rufino Borrego was 13, he was diagnosed by a Lisbon hospital as having incurable muscular dystrophy, the Jornal de Noticias reported.
After that he used a wheelchair to get around for more than four decades - until a neurologist realised in 2010 that he in fact suffered from a different disease that weakens the muscles, myasthenia.
The rare disease can be treated simply by taking asthma medication - and just a year after his new diagnosis, Borrego was able to walk for the first time to his usual neighbourhood cafe.
Now aged 61, Borrego is able to live a normal life, requiring only two physiotherapy sessions a year.
He insists he harbours no ill-feelings against the hospital that made the original diagnosis, acknowledging that myasthenia was almost unknown in the medical profession in the 1960s.
"I just want to make use of my life," he said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
